From the Editor

No mystery about hypnosis

Author and Disclosure Information

 

Hypnosis’ decline in psychiatric training programs is surprising, given today’s emphasis on short-term therapies. Hypnosis can be very useful—particularly for patients with anxiety disorders, phobias, and posttraumatic stress disorder—as David Spiegel, MD, of Stanford University writes in his thoughtful scientific review.

My first experience with hypnosis was as a University of North Carolina undergraduate, when a psychology professor did a group hypnotic induction. I scored 7 out of 12 on the Stanford Hypnotic Susceptibility Scale (SHSS), which indicated I was “moderately” hypnotizable. I felt good because the professor said hypnotizable people are curious, brave, and open to new experiences.

Later, as a Stanford University medical student, I was hired as a hypnotist at the Stanford Hypnotic Research Center. My job was to administer a new 5-point SHSS to undergraduates who had been screened with the 12-point version. The shorter version included a 30-minute hypnotic induction—instead of the regular 60 minutes—and was designed for clinical practice.

For 6 months I immediately hypnotized every student, and they all scored at the top of the scale. Naturally, I assumed I was God’s gift to hypnosis. My euphoria ended abruptly, however, when one student scored zero. Rather than going into a trance, he stared at me for a half-hour with pity and mild aggression in his eyes.

From then on, every subject behaved the same way, and none scored more than 1 point. I resigned because I couldn’t take it anymore. Later, I got over my narcissistic wound when I realized I had been involved in a blinded experiment to see how well the shorter scale evaluated students who scored very high or very low on the longer version.

Despite this setback, I have used hypnosis over the years to help treat a variety of psychiatric conditions, with varying degrees of success. I have never, however, regained a belief in my own singularity.

Recommended Reading

Treatment-resistant depression: Is there any other kind?
MDedge Psychiatry
Update on eating disorders Anorexia nervosa: Dual therapy can bring patients back from the brink
MDedge Psychiatry
Chemical ‘warfare’ in Philadelphia
MDedge Psychiatry
Prescribing to preserve or restore sexual function
MDedge Psychiatry
Revised ‘SAD PERSONS’ helps assess suicide risk
MDedge Psychiatry
Using a ‘MAP’ to navigate follow-up visits
MDedge Psychiatry
Beating the high cost of software
MDedge Psychiatry
Treatment-resistant depression: Switch or augment? Choices that improve response rates
MDedge Psychiatry
SSRIs in children and adolescents: Where do we stand?
MDedge Psychiatry
Brain/body connection: Treating depression in patients with cardiovascular disease
MDedge Psychiatry